In an April 20 blog post, Mr. Shkreli said the healthcare virtual assistant, dubbed DrGupta.AI, would be able to help patients “access health information and simulate interactions with a physician.”
In the post, Mr. Shkreli blamed high healthcare costs on physician decisions and argued that healthcare is more expensive due to a “constrained supply of healthcare professionals.”
Mr. Shkreli said a remedy for this could be large language models such as ChatGPT.
“Dr. Gupta may not be ready to replace physicians entirely, but I believe it has the potential to be a valuable resource for many individuals,” Mr. Shkreli wrote.
DrGupta.AI, according to Mr. Shkreli, can perform tasks such as interpreting medical papers, textbooks or news articles.
The move comes shortly after a federal court banned him from serving as an executive or director at a public company. But, according to the the Federal Trade Commission, he has violated this order by forming and operating a new company called Druglike.
According to a court document filed Jan. 20, Mr. Shkreli did not comply with the FTC’s requests to submit documents and be interviewed concerning the new company.
